NOAH Compendium

Printed from NOAH Compendium (https://www.noahcompendium.co.uk). (c) Copyright NOAH Compendium 2025. All Rights Reserved.
Date: Sunday, June 15, 2025 22:23

Release 4.131
Nobilis® IB 4-91 lyophilisate for oculonasal suspension/use in drinking water for chickens
Species: Chickens, Poultry
Therapeutic indication: Immunological veterinary medical products: For poultry, For chickens
Active ingredient: Vaccine Antigens
Product:Nobilis® IB 4-91 lyophilisate for oculonasal suspension/use in drinking water for chickens
Product index: Nobilis® IB 4-91
Poultry - meat: Zero days
Incorporating:
Qualitative and quantitative composition
Each dose of reconstituted vaccine contains:
Active substance:
Live attenuated avian Infectious Bronchitis Virus (IBV) variant strain 4-91: ≥ 3.6 log10 EID50*
*EID50 = 50% Embryo infective dose: the virus titre required to produce infection in 50% of the embryos inoculated.
For a full list of excipients, see section 'Pharmaceutical particulars'.
Pharmaceutical form
Lyophilisate:
Vials: off-white/cream-coloured pellet.
Cups: off-white, predominantly sphere shaped.
Clinical particulars
<
p class="p-left" id="A-455132_35">
Target species
Chickens.
Indications for use
Active immunisation of chickens to reduce the respiratory signs of Infectious Bronchitis caused by the IBV variant strain 4-91.
Onset of immunity: 3 weeks.
Duration of immunity: 6 weeks.
Contraindications
None.
Special warnings for each target species
Vaccinate healthy animals only.
Special precautions for use
Nobilis IB 4-91 is intended to protect chickens against respiratory signs of disease caused by IBV variant strain 4-91 only and should not be used as a replacement for other IBV vaccines.
The product should only be used after it has been established that IBV variant strain 4-91 is epidemiologically relevant in the area. Care should be taken to avoid the introduction of the variant strain into an area where it is not present.
Care should be taken to avoid spread of the vaccine virus from vaccinated chickens to pheasants.
The vaccine virus may spread from vaccinated to non-vaccinated chickens and appropriate care should be taken to separate vaccinated from non-vaccinated chickens.
Wash and disinfect hands and equipment after vaccinating to avoid spread of the virus.
Operator warnings
In case of spray administration, personal protective equipment consisting of masks with eye protection should be worn when handling the veterinary medicinal product.
Adverse reactions
Chickens:
Very common (>1 animal / 10 animals treated):
Respiratory signs1
1May persist for a few days.
Use during pregnancy, lactation or lay
Nobilis IB 4-91 has been shown to be safe in layers and breeders during lay.
Interactions
Safety and efficacy data are available which demonstrate that:
- This vaccine can be mixed and administered with Nobilis IB Ma5 for spray or intranasal/ocular administration to commercial chicks from one day of age onwards. For the mixed products the onset of immunity is 3 weeks, and the duration of immunity is 6 weeks for the claimed protection against Massachusetts and variant strain 4-91 of IBV. The safety parameters of the mixed vaccines are not different from those described for the vaccines administered separately. Simultaneous use of both vaccines increases the risk of recombination of viruses and potential emergence of new variants. However, the chance of a hazard occurring has been estimated very low and is minimized by routinely vaccinating all chickens on the premise at the same time and cleaning and disinfection after each production round. Read the product information of Nobilis IB Ma5 before use.
- Nobilis IB 4-91 can be administered to day-old chicks that are vaccinated either by the subcutaneous or in ovo route with Innovax-ND-IBD.
- Nobilis IB 4-91 can be administered to day-old chicks that are vaccinated either by the subcutaneous or in ovo route with Innovax-ND-ILT
Nobilis IB 4-91 given at day-old can adversely affect the efficacy of turkey rhinotracheitis (TRT) vaccine given within 7 days.
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Amounts to be administered and administration route
General
Administration of 1 dose per animal by:
- oculonasal use (coarse spray or intranasal/ocular administration); or
- in drinking water use.
The vaccine may be delivered as a freeze-dried cake in a glass vial or as freeze-dried spheres in cups. In case of the latter presentation the cups may contain 3 up to 100 spheres depending on the required dosages and production yields.
In case of the product presented in cups, do not use the product if the contents are brownish and stick to the container as this indicates that the integrity of the container has been breached. Each container should be used immediately and completely after opening.
Guideline/vaccination scheme
Broiler: The vaccine can be administered to 1-day-old chicks and older chickens by coarse spray or by intranasal/ocular administration. The vaccine can be administered to 7‑day and older chickens by drinking water.
Future layers and breeders: The vaccine can be administered to future layers and breeders from day old onwards via intranasal/ocular route or coarse spray. The vaccine can be administered to 7‑day and older chickens by drinking water. For prolonged immunity, chickens should be revaccinated every 6 weeks after the initial administration.
Ocular/intranasal administration or coarse spray gives the best responses, and these should be the methods of choice, especially when vaccinating young chickens.
Drinking water use
The vials should be opened under water or the content of the cup(s) should be poured into the water. In both cases mix the water containing the vaccine well before use. After reconstitution the suspension looks clear.
Use cool, clean water to dissolve the vaccine. For administration of the vaccine, as a general rule, dissolve 1,000 doses in one litre per age in days up to a maximum volume of 20 litres per 1,000 doses. For heavy breeds, or in hot weather, the quantity of water may be increased up to 40 litres per 1,000 doses. By adding approximately 2 grams of skimmed milk powder or 20 ml of liquid skimmed milk per litre of water the virus retains its activity longer.
Ensure that all the vaccine suspension is consumed within 1 - 2 hours. The vaccine should be given in the early morning as this is the main period of water intake or during the cool period on a hot day. Feed should be available when vaccinating. Water should be withheld before vaccination to make the chickens thirsty. The length of time of water deprivation is strongly dependent on the climatological circumstances. Water withholding should be kept as short as possible with a minimum of half an hour. A sufficient number of water containers to provide adequate drinking space is essential. These should be clean and free from traces of detergents and disinfectants.
Turn on mains water when all the vaccine water has been consumed.
Spray method
The vaccine should preferably be dissolved in distilled water or alternatively in cool, clean water. The appropriate number of vials should be opened under water or the content of the cup(s) should be poured into the water. In both cases mix the water containing the vaccine well before use. After reconstitution the suspension looks clear.
The volume of water for reconstitution should be sufficient to ensure an even distribution when sprayed onto the chickens. This will vary according to the age of the chickens being vaccinated and the management system, but 250 to 400 ml of water per 1,000 doses is suggested. The vaccine suspension should be spread evenly over the correct number of chickens, at a distance of 30–40 cm using a coarse spray, preferably when the chickens are sitting together in dim light. The spray apparatus should be free from sediments, corrosion and traces of disinfectants and ideally should be used for vaccination purposes only.
Intranasal/ocular administration
Dissolve the vaccine in physiological saline solution or sterile distilled water (usually 30 ml per 1,000 doses, 75 ml per 2,500 doses) and administer by means of a standardized dropper. One drop should be applied onto one nostril or one eye. Ensure that the nasal drop is inhaled before freeing the bird.
Vaccination programme:
The veterinarian should determine the optimum vaccination schedule according to the local situation.
Guideline when the product is used with Nobilis IB Ma5:
The instructions on reconstitution of both lyophilisates and the subsequent application are to be followed as outlined above for spray and intranasal/ocular administration. The same volumes as for the single product should be used.
In-use shelf life after mixing: 2 hours.
Overdose
Ten times the maximum dose was shown to be safe for the target species by all the recommended routes and methods of administration.
Withdrawal period
Zero days.
Pharmacological particulars
Immunological properties
ATCvet code: QI01AD07.
Pharmacotherapeutic group: Immunologicals for Aves, domestic fowl, live viral vaccine, avian infectious bronchitis virus.
Active immunisation against avian Infectious Bronchitis virus variant strain IB 4-91 which causes infectious bronchitis in chickens.
Pharmaceutical particulars
Excipients
Sorbitol
Gelatine
Pancreatic digest of casein
Disodium phosphate
Water for injections
Major Incompatibilities
Do not mix with any other veterinary medicinal product, except Nobilis IB Ma5 recommended for use with the veterinary medicinal product.
Shelf life
Shelf life of the veterinary medicinal product in glass vials as packaged for sale: 9 months.
Shelf life of the veterinary medicinal product in aluminium laminate cups as packaged for sale: 24 months.
Shelf life after reconstitution according to directions: 2 hours.
Special precautions for storage
Store in a refrigerator (at 2 °C - 8 °C).
Do not freeze.
Protect from light.
Immediate packaging
Lyophilisate
Glass vial (type I hydrolytic glass) of 10 ml containing 500, 1,000, 2,500, 5,000 or 10,000 doses closed with a halogenobutyl rubber bung and sealed with a coded aluminium cap.
Sealed aluminium laminate cup with a polypropylene (cup) and polypropylene/polyethylene (lid) contact layer containing 1,000, 2,500, 5,000 or 10,000 doses.
Packaging
Cardboard box with 1 or 10 vials of 500 doses.
Cardboard box with 1 or 10 vials of 1,000 doses.
Cardboard box with 1 or 10 vials of 2,500 doses.
Cardboard box with 1 or 10 vials of 5,000 doses.
Cardboard box with 1 or 10 vials of 10,000 doses.
Cardboard box with 10 cups of 1,000 doses.
Cardboard box with 10 cups of 2,500 doses.
Cardboard box with 10 cups of 5,000 doses.
Cardboard box with 10 cups of 10,000 doses.
PET plastic box with 12 cups of 1,000 doses.
PET plastic box with 12 cups of 2,500 doses.
PET plastic box with 12 cups of 5,000 doses.
PET plastic box with 12 cups of 10,000 doses.
Not all pack sizes may be marketed.
Disposal
Medicines should not be disposed of via wastewater.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.
Marketing Authorisation Holder (if different from distributor)
UK(NI): Intervet International B.V., The Netherlands
Marketing Authorisation Number
UK(GB): Vm 01708/5043
UK(NI): EU/2/98/006/001-018
Significant changes
Date of the first authorisation or date of renewal
21 May 2008
Date of revision of the text
(UK)NI - August 2023
(UK)GB - January 2024
Any other information
For animal treatment only. Keep out of the sight and reach of children.
Legal category
Legal category: POM-V
GTIN
GTIN description:Nobilis IB 4-91 10x1000ds:
GTIN:08713184155740,
GTIN description:Nobilis IB 4-91 10x2500ds:
GTIN:08713184054401,
GTIN description:Nobilis IB 4-91 10x5000ds:
GTIN:8713184157010